Newcastle diseases virus strain V4UPM displayed oncolytic ability against experimental human malignant glioma

REFERENCES

• Omar AR, Idens A, Manaf AA, et al. An overview on the development of Newcastle disease virus as an anti-cancer therapy. Ma/ays J Med Sci 2003; 10: 4–12
   Google Scholar
• Elankumaran S, Rockemann D, Samal SK. Newcastle diseases virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death. J Virol 2006; 80: 7522–7534
   PubMed Web of Science ®Google Scholar
• Washburn B, Weigand MA, Gross-Wild A, et al. TNF-related apoptosis-inducing I igand mediates tumoricidal activity of human monocytes stimulated by Newcastle diseases virus. I Immunol 2003; 170: 1814–1821
   PubMed Web of Science ®Google Scholar
• Phuangsab A, Lorence RM, Reichard KW, et al. NDV therapy of human tumor xenografts: Antitumor effect of local or systemic administration. Cancer Lett 2001; 172: 27–36
   PubMed Web of Science ®Google Scholar
• Reichard KW, Lorence RM, Cascino CJ, et al. Newcastle disease virus selectively kills human tumor cells. ] Surg Res 1992; 52: 448–453
   PubMed Web of Science ®Google Scholar
• Castary LK, Bakacs T. Use of Newcastle disease virus vaccine (MTH-68/H) in a patient with high-grade glioblastoma. JAMA 1999; 281: 1588–1589
   Google Scholar
• Sinkovics JG, Horvath JC. Newcastle disease virus (NDV): Brief history of its oncolytic strains. J Clin Virol 2000; 16: 1–15
   PubMed Web of Science ®Google Scholar
• Yusoff K, Tan WS. NDV: Macromolecules and opportunity. Avian Pathol 2001; 30: 439–455
   PubMed Web of Science ®Google Scholar
• Tanaka S, Kawai K, Nakai S, et al. Apoptosis-Inducing activity and growth suppression by vesnarinone on human glioma transplanted in nude mice. Neurol Res 1999; 21: 409–414
   PubMed Web of Science ®Google Scholar
• Sundaresan P, William DH, Robert LM, et al. Attenuated, replication-competent herpes simplex virus type 1 mutant G207: Safety evaluation in mice. J Virol 2000; 74: 3832–3841
   PubMed Web of Science ®Google Scholar
• Reichard KW, Lorence RM, Katubig BB, et al. Retinoic acid enhances killing of neuroblastoma cells by Newcastle disease virus. J Pediatr Surg 1993; 28: 1221–1226
   PubMedGoogle Scholar
• Salih O. Omar AR, Ali AM, et al. Nucleotide sequence analysis of the F protein gene of a Malaysia velogenic NDV strain AF2240. J Biochem Biophys 2000; 4: 51–57
   Google Scholar
• Lorence RM, Katubig BB, Reichard KW, et al. Complete regression of human fibrosarcoma xenograft after local NDV therapy. Cancer Res 1994; 54: 6017–6021
   PubMed Web of Science ®Google Scholar
• Schirrmacher V, Griesbach A, Ahlert T. Antitumor effects of NDV in vivo: Local versus systemic effects. Int J Oncol 2001; 18: 945–952
   PubMed Web of Science ®Google Scholar
• Hegedus B, Czirok A, Fazekas I, et al. Locomotion and proliferation of glioblastoma cells in vitro: Statistical evaluation of video microscopic observations. J Neurosurg 2000; 92: 428–434
   PubMed Web of Science ®Google Scholar
• Liu TC, Kim D. Viruses with deletion in antiapoptotic genes as potential oncolytic agents. Oncogene 2005; 24: 6069–6079
   PubMed Web of Science ®Google Scholar
• Conaris H, Takimoto T, Russel R, et al. Probing the sialic acid binding site of the hemagglutinin-neuraminidase of Newcastle disease virus: Identification of key amino acids involved in cell binding, catalysis, and fusion. J Virol 2002; 76: 1816–1824
   PubMedGoogle Scholar
• Fabian Z, Torocsik B, Kiss K, et al. Induction of apoptosis by a Newcastle diseases virus vaccine (MTH-68/H) in PC12 rat phaeochromocytoma cells. Anticancer Res 2001; 21: 125–136
   PubMed Web of Science ®Google Scholar
• Narayani M, Fauziah O. Abd Rahman O. et al. Cytotoxicity assay and transmission electron microscopy of MCF-7 breast cancer cell line treated with local strains of Newcastle disease virus (NDV). Ann Microsc 2003; 3: 36–42
   Google Scholar
• Csatary LK, Gosztonyi G, Fabian Z, et al. MTH-68/H oncolytic viral treatment in human high-grade gliomas. J Neurooncol 2004; 67: 83–93
   PubMed Web of Science ®Google Scholar
• Liang W, Wang H, Sun TM, et al. Application of Autologous tumor cell vaccine and NDV vaccine in treatment of tumors of digestive tract. World] Gastroenterol 2003; 9: 495–498
   PubMed Web of Science ®Google Scholar
• Pecora AL, Rizvi N, Cohen GI, et al. Phase I trial of intravenous administration of PV701, an oncolytic virus, In patients with advance solid cancer. ] Clin Oncol 2002; 20: 2251–2266
   PubMed Web of Science ®Google Scholar
• McKinney PA. Brain tumors: Incidence, survival, and aetiology. J Neurol Neurosurg Psychiatry 2004; 75: 12–17
   Web of Science ®Google Scholar
• Kuratsu J, Ushio Y. Epidemiology study of primary intracranial tumors in elderly people. ] Neurol Neurosurg Psychiatry 1997; 63: 116–118
   PubMedGoogle Scholar
• CBTRUS. Primary Brain Tumors in the United States Statistical Report 1995-1999, Chicago, IL: Central Brain Tumor Registry of the United States, 2002
   Google Scholar
• Mathers CD, Vos T, Stevenson CE. The Burden of Disease and Injury in Australia, AIHW PHE 17, Canberra: Australian Institute of Health and Welfare, 1999
   Google Scholar
• Alexander DJ. Paramyxoviridae (Newcastle disease and others). In: F. T. W. Jordan, ed. Poultry Diseases, 3rd edn, London: Bailliere Tindall, 1990: pp. 122-133
   Google Scholar
• Reynolds CP, Sun BC, DeClerck YA, et al. Assessing growth and response to therapy in murine tumors models. Methods Mol Med 2005; 111: 335–50
   PubMedGoogle Scholar
• Wilcox ME, Yang MQ, Senger D, et al. Reovirus as an oncolytic agent against experimental human malignant gliomas. J Natl Cancer Inst 2001; 93: 903–912
   PubMed Web of Science ®Google Scholar
• Aini I, Latif I, Spradbrow PB, et al. Development of food pellet Newcastle disease vaccine. In J. W. Copland, ed. Newcastle Disease in Poultry: A New Food Pellet Vaccine, Brisbane: Etching Press, 1987: pp. 20–25
   Google Scholar
• Toyoda H, Ido M, Hayashi T, et al. Experimental treatment of human neuroblastoma using live-attenuated poliovirus. Intl Oncol 2004; 24: 49–58
   Google Scholar
• French EL, St George TD, Percy JJ. Infection of chicks with recently isolated Newcastle disease viruses of low virulence. Austral Vet J 1967; 43: 404–409
   PubMedGoogle Scholar
• Spadbrow PB. Newcastle disease — an overview. In: J. W. Copland, ed. Newcastle Disease in Poultry: A New Food Pellets Vaccine, Brisbane: Etching Press, 1987: pp. 12–18
   Google Scholar
• Ribble D, Goldstein NB, Norris AD, et al. A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol 2005; 5: 12
   PubMed Web of Science ®Google Scholar